Drugs & Targets FDA approves first treatment for Erdheim-Chester Disease November 10, 2017Vol.43 No.42
Drugs & Targets FDA approves Adcetris for cutaneous anaplastic large cell lymphoma November 10, 2017Vol.43 No.42
Drugs & Targets Seattle Genetics submits sBLA for Adcetris in Hodgkin lymphoma November 10, 2017Vol.43 No.42
Drugs & Targets FDA approves Kite’s CAR-T cell therapy; another win for NCI’s intramural program November 07, 2017Vol.40 No.09By Matthew Bin Han Ong
Drugs & Targets FDA approves AstraZeneca’s Calquence for mantle cell lymphoma November 03, 2017Vol.43 No.41
Drugs & Targets Consortium aims to accelerate preclinical cancer drug discovery November 03, 2017Vol.43 No.41
Drugs & Targets FDA accepts Genentech’s application for Avastin for advanced ovarian cancer October 27, 2017Vol.43 No.40
Drugs & Targets G100 receives Orphan Drug Designation from EMA for follicular non-Hodgkin’s lymphoma October 27, 2017Vol.43 No.40
Drugs & Targets FDA Accepts BMS application for Opdivo for resected high-risk advanced melanoma October 20, 2017Vol.43 No.39
Drugs & Targets FDA grants priority review for Lilly’s Verzenio (abemaciclib) for advanced breast cancer October 13, 2017Vol.43 No.38
